Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Inosine Monophosphate Dehydrogenase Type II from Human, Recombinant
Cat No.
NATE-0352
Description
Type II is the predominant IMPDH isoform and is specifically linked to a wide range of cancers and lymphocyte proliferation.
Abbr
IMPDH2, Recombinant (Human)
Alias
IMPDH II; IMPDH2; IMPD 2
Source
E. coli
Species
Human
Package
vial of > 0.002 unit
Form
Solution in 20 mM Tris-HCl, pH 8.0, containing 0.5 mM EDTA and 1 mM DTT.
Enzyme Commission Number
EC 1.1.1.205
CAS No.
231-791-2
Unit Definition
One unit will produce 1.0 μ mole of XMP from IMP with corresponding reduction of β-NAD per minute at pH 8.0 at 25°C.
Storage
−70°C
Pathway
Drug metabolism-other enzymes, organism-specific biosystem; Drug metabolism-other enzymes, conserved biosystem; Metabolic pathways, organism-specific biosystem; Metabolism, organism-specific biosystem; Metabolism of nucleotides, organism-specific biosystem; Purine metabolism, organism-specific biosystem; Purine metabolism, organism-specific biosystem
Function
DNA binding; IMP dehydrogenase activity; RNA binding; metal ion binding; nucleotide binding; oxidoreductase activity
Synonyms
inosine-5'-phosphate dehydrogenase; inosinic acid dehydrogenase; inosinate dehydrogenase; inosine 5'-monophosphate dehydrogenase; inosine monophosphate dehydrogenase; IMP oxidoreductase; inosine monophosphate oxidoreductase; IMP dehydrogenase; IMP:NAD+ oxidoreductase; EC 1.1.1.205; IMPDH II; IMPDH2; IMPD 2
Download
Download Datasheet| Catalog | Product Name | EC No. | CAS No. | Source | Price |
|---|---|---|---|---|---|
| NATE-1739 | Inosine Monophosphate Dehydrogenase from Staphylococcus aureus, Recombinant | EC 1.1.1.205 | 9028-93-7 | S. aureus | Inquiry |
| EXWM-0109 | IMP dehydrogenase | EC 1.1.1.205 | 9028-93-7 | Inquiry |